XTalks

AUGUST 18, 2020

The test has been developed by researchers at the Yale School of Public Health and is being touted as a game changer for fast and easy COVID testing. Having a test that requires less reagents and resources, such as the RNA extraction kits, increases capabilities for increased testing. Non-Proprietary Technology.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

Roots Analysis

FEBRUARY 21, 2022

Since the introduction of a gene sequencing method by Frederick Sanger in 1977, the field of genomic data collection and analysis has evolved significantly. Advancement in DNA sequencing technologies have resulted in noteworthy developments in various healthcare-related research fields, such as diagnostics and personalized medicine.

Marketing 52

Marketing Gene Sequencing DNA Genome 52

The Pharma Data

MARCH 20, 2021

The Challenge: The demands of many labs simultaneously beginning COVID-19 screening programs are leading to a scarcity of resources like pipette tips and reagents. Medicine in Oxford, Biogazelle, a biotechnology company in Ghent, and the Centre For Proteome Research at the University of Liverpool. delays where reagents are in.

Reagent 52

Reagent RNA Bioinformatics Medicine 52

Roots Analysis

FEBRUARY 23, 2022

NGS has emerged as an evolutionary technology in modern biotechnology and healthcare research, enabling researchers to develop a better understanding of the cause and consequences of disease. During our research, we came across more than 280 NGS library preparation kits, that are presently available in the market.

Genetics 52

Genetics DNA RNA Reagent 52

Pharmaceutical Technology

FEBRUARY 15, 2023

Outlook The era of mRNA-based genomic medicines is on the horizon. PNI’s GenVoy Delivery Platform comprises off-the-shelf RUO reagents such as GenVoy-ILM and a library of proprietary lipids available as custom formulations. The technology underpinning the COVID-19 vaccines are the tip of the iceberg.

Bioassay 130

Bioassay RNA Development Drugs 130

XTalks

JANUARY 21, 2025

Unipure C3F8 Ophthalmic Gas, Unifeye Gas Delivery System, Unipexy Gas Delivery System Manufacturer/developer : Alcon Research, LLC Date of FDA approval : July 2, 2024 Approved for : Treating uncomplicated retinal detachments. The Onclarity HPV reagent pack extraction combo. Photo courtesy of BD.

FDA Approval 105

FDA Approval Manufacturing Development RNA 105

The Pharma Data

JANUARY 24, 2021

“Adding Chris to our leadership team will bolster our preclinical pipeline and translational research capabilities to accelerate development of the company’s cell therapy candidates from discovery into clinical application.” at Sunnybrook Research Institute and Peter Zandstra , Ph.D.,

Engineer 52

Engineer Gene Editing Genome Genomics 52

The Pharma Data

DECEMBER 2, 2020

Howard Mayer, Ipsen’s head of research and development, called the Fast Track designation for Onivyde “an extension of Ipsen’s focus and contribution” to the oncology landscape. The license from ERS Genomics now enables Vivlion to offer both R&D reagents and screening services to its customers worldwide. in Mainland China.

Drugs 52

Drugs Gene Editing Genome Genomics 52

The Pharma Data

OCTOBER 14, 2020

They offer access to an intact genome which allows whole genome sequencing without a background. 2) Prenatal Diagnostics : circulating throphoblasts in maternal blood can provide a comprehensive, non-invasive picture of a fetus as well as access to an intact genome. Whole cells are precious biomarkers.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Genome 40

Advarra

NOVEMBER 29, 2022

The field of cell and gene therapies (CGT) is constantly evolving, and there has been significant progress in this area of research. Dealing with confusing regulatory guidelines is one of the top obstacles researchers face as they develop CGT products 1. Recent Problems in Cell and Gene Therapy Development.

Gene Therapy 52

Gene Therapy Gene Production Clinical Trials 52

XTalks

OCTOBER 19, 2023

They typically work in the biotechnology, pharmaceutical and diagnostic sectors as well as in academic research, having pivotal roles in the early stages of drug discovery, research and diagnostic tool development by creating reliable tests that can provide essential data on biological samples.

Scientist 59

Scientist Development Research Compliance 59

The Pharma Data

OCTOBER 14, 2020

AOP anticipates new opportunities in Austria as a hub for research and business. The new services have been developed to support pre-clinical research by optimizing hiPSC-derived cell culture, while providing high-quality electrophysiological data acquisition and analysis from physiologically relevant human cell models. Ltd of Japan.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing In-Vivo 52

The Pharma Data

JANUARY 20, 2021

Laboratory Implementation Laboratory reagents for performing the test commercially have been designed and are currently being validated in preparation for regulatory submission to CMS/CLIA with a view to targeting sales in the USA initially. This is also expected to provide greater flexibility for potential distribution partners.

Genetics 40

Genetics Reagent Biobanking Production 40

XTalks

JANUARY 6, 2025

Whether its the integration of nanotechnology in medicine, the evolution of point-of-care (POC) diagnostics or the transformative impact of CRISPR and regenerative medicine, these biotech trends are pushing scientific boundaries and creating new opportunities for businesses and researchers alike. billion by 2031.

Gene Therapy 111

Gene Therapy RNA Gene Editing Gene 111

Roots Analysis

JANUARY 27, 2025

Large-scale Production: When the proteins are successfully active, the processes are scaled up to meet the demands of large-scale research or industrial applications, ensuring the production of functional proteins in substantial quantities. Authors Bio Akarshika Singh is a business research analyst and competitive intelligence professional.

Protein 40

Protein Reagent Marketing Gene 40